Increasing hemoglobin concentration with an artificial oxygen carrier improves severe anemia-induced degraded cognitive function

J Trauma Acute Care Surg. 2021 Aug 1;91(2S Suppl 2):S182-S185. doi: 10.1097/TA.0000000000003261.

Abstract

Before death, patients commonly experience impaired consciousness for a significant period, frequently preventing family and others from final interactions with the patient. Some of these episodes of cognitive impairment may be treatable, with treatment not offered owing to the perception of ultimate futility or expense, or both. One of the causes of terminal loss of consciousness or decreased lucidity can be inadequate cerebral oxygen delivery. We report five cases from four institutions where an infusion of a hemoglobin-based oxygen carrier to patients who were unconscious or not lucid owing to acute severe anemia (hemoglobin range, 2.1-5.2 g/dL) resulted in awakening or lucidity. We review briefly human cognitive function and anemia and remark about the use of a hemoglobin-based oxygen carrier for acute severe anemia when red cell transfusion is not an option.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anemia / complications*
  • Anemia / drug therapy
  • Blood Substitutes / therapeutic use*
  • Cognitive Dysfunction / etiology
  • Cognitive Dysfunction / prevention & control*
  • Consciousness / drug effects
  • Female
  • Hemoglobins / therapeutic use
  • Humans

Substances

  • Blood Substitutes
  • Hemoglobins
  • HBOC 201